Flomoxef Explained

Flomoxef is an oxacephem antibiotic that was developed by Shionogi.

It has been classified either as a second-generation [1] or fourth-generation cephalosporin.[2]

It was patented in 1982 and approved for medical use in 1988 under the trade name Flumarin.[3]

Notes and References

  1. Masuda Z, Kurosaki Y, Ishino K, Yamauchi K, Sano S . Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration . General Thoracic and Cardiovascular Surgery . 56 . 4 . 163–169 . April 2008 . 18401677 . 10.1007/s11748-007-0208-5 . 23845740 .
  2. Ito M, Ishigami T . The meaning of the development of flomoxef and clinical experience in Japan . Infection . 19 . Suppl 5 . S253–S257 . 1991 . 1783441 . 10.1007/bf01645536 . 25339977 .
  3. Book: Fischer J, Ganellin CR . Analogue-based Drug Discovery . 2006 . John Wiley & Sons . 9783527607495 . 496 . en.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Flomoxef".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.